---
schema_version: "secwatch.filing_event.v1"
accession: "0002007919-25-000063"
form_type: "8-K"
ticker: "INBX"
cik: "0002007919"
company_name: "Inhibrx Biosciences, Inc."
filed_at: "2025-05-28T23:59:59+00:00"
generated_at: "2026-05-20T08:59:56.851469+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Inhibrx stockholders elect two Class I directors, ratify auditor at 2025 annual meeting

## Summary
- Jon Faiz Kayyem, Ph.D. elected with 8,077,611 votes for, 31,060 withheld (3,384,613 broker non-votes).
- Kristiina Vuori, M.D., Ph.D. elected with 6,494,317 votes for, 1,614,354 withheld (3,384,613 broker non-votes).
- Ratification of BDO USA as auditor passed with 11,463,328 for, 2,918 against, 27,038 abstained.
- Quorum of 11,493,284 shares (79% of eligible) was present at the May 28, 2025 virtual meeting.

## SEC filing metadata
- accession: 0002007919-25-000063
- form_type: 8-K
- ticker: INBX
- cik: 0002007919
- company_name: Inhibrx Biosciences, Inc.
- filed_at: 2025-05-28T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2007919/000200791925000063/0002007919-25-000063-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2007919/000200791925000063/inhibrx-20250528.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0002007919-25-000063
- JSON: https://secwatch.observer/filing/0002007919-25-000063.json
- Plain text: https://secwatch.observer/filing/0002007919-25-000063.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.